Updates

Plus500

June 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

In an effort to access new markets online, CFD provider Plus500 has announced the acquisition of Cunningham Commodities, an Illinois, USA-based, regulated Futures Commission Merchant and software company, which has developed a sophisticated technology trading platform. The US$30m deal expands Plus’ footprint into the “growing but under penetrated” US retail trading market in futures and options on futures, with retail volumes growing 84% since 2017. Cunningham had sales of US$19m and pretax profit of US$0.6m and it’s expected to be eps enhancing in its first full year.With net cash of nearly US$600m, I am expecting more M&A to reduce reliance on the volatile CFD market. Highlighted at just 749p in De ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

De La Rue

Medica

Plus500 (January 2025)

Plus500 - Highest returning stock over past 11 years; eyes US and Japan for future growth (November 2024)

Plus500 - Has returned an incredible 11.5x its IPO market value via dividends and buy-backs! (October 2024)

Plus500 - CFD trading firm enjoys double-digit upgrade (February 2024)

Plus500 (September 2021)

Plus500 (April 2021)

Plus500 (December 2020)

Plus500 (November 2020)

Plus500 - Shares surge towards £15 (October 2020)

Plus500 - Q2 revenues up 162%! (September 2020)

Plus500 (August 2020)

Plus500 - Second upgrade in a month (June 2020)

Plus500 - Significant director buying (April 2020)

Plus500 (February 2020)

Plus500 - Shares very cheap on ex-cash PE of 5.3 (December 2019)

Plus500 (September 2017)

Plus500 (January 2017)

Plus500 - Soon-to-be prospective PE just 6.6 (December 2016)

Plus500 - CFD trading firm a serious rival to IG (October 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X